Disc Medicine, Inc. (IRON)
55.74
-0.86
(-1.52%)
USD |
NASDAQ |
Oct 14, 16:00
55.68
-0.06
(-0.11%)
Pre-Market: 20:00
Disc Medicine Price to Book Value : 3.318 for Oct. 14, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 14, 2026 | 3.318 |
| October 13, 2026 | 3.369 |
| October 12, 2026 | 3.600 |
| October 09, 2026 | 3.694 |
| October 08, 2026 | 3.618 |
| October 07, 2026 | 3.642 |
| October 06, 2026 | 3.670 |
| October 05, 2026 | 3.770 |
| October 02, 2026 | 3.840 |
| October 01, 2026 | 3.787 |
| September 30, 2026 | 3.897 |
| September 29, 2026 | 3.921 |
| September 28, 2026 | 3.864 |
| September 25, 2026 | 3.884 |
| September 24, 2026 | 3.955 |
| September 23, 2026 | 3.934 |
| September 22, 2026 | 4.076 |
| September 21, 2026 | 4.077 |
| September 18, 2026 | 4.139 |
| September 17, 2026 | 4.118 |
| September 16, 2026 | 4.082 |
| September 15, 2026 | 4.006 |
| September 14, 2026 | 4.103 |
| September 11, 2026 | 4.170 |
| September 10, 2026 | 4.413 |
| Date | Value |
|---|---|
| September 09, 2026 | 4.554 |
| September 08, 2026 | 4.574 |
| September 04, 2026 | 4.716 |
| September 03, 2026 | 4.725 |
| September 02, 2026 | 4.765 |
| September 01, 2026 | 4.683 |
| August 31, 2026 | 4.682 |
| August 28, 2026 | 4.764 |
| August 27, 2026 | 4.914 |
| August 26, 2026 | 4.921 |
| August 25, 2026 | 4.906 |
| August 24, 2026 | 4.818 |
| August 21, 2026 | 4.751 |
| August 20, 2026 | 4.693 |
| August 19, 2026 | 4.781 |
| August 18, 2026 | 4.774 |
| August 17, 2026 | 4.765 |
| August 14, 2026 | 4.693 |
| August 13, 2026 | 4.763 |
| August 12, 2026 | 4.797 |
| August 11, 2026 | 4.834 |
| August 10, 2026 | 4.660 |
| August 07, 2026 | 4.610 |
| August 06, 2026 | 4.610 |
| August 05, 2026 | 4.697 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Recursion Pharmaceuticals, Inc. | 2.183 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 19.71 |
| Anika Therapeutics, Inc. | 1.974 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PEG Ratio | -0.1803 |
| Price | 55.74 |
| Earnings Yield | -11.80% |
| Market Cap | 2.137B |
| PEGY Ratio | -0.1803 |